Guthrie, B. ., Rogers, G. ., Livingstone, S. ., Morales, D. R., Donnan, P. ., Davis, S. ., … Payne, K. . (2024). The implications of competing risks and direct treatment disutility in cardiovascular disease and osteoporotic fracture: risk prediction and cost effectiveness analysis. Health Soc Care Deliv Res, 12, 1–275. http://doi.org/10.3310/kltr7714
A. Thompson
First name
A.
Last name
Thompson
Livingstone, S. J., Guthrie, B. ., Donnan, P. T., Thompson, A. ., & Morales, D. R. (2022). Predictive performance of a competing risk cardiovascular prediction tool CRISK compared to QRISK3 in older people and those with comorbidity: population cohort study. BMC Med, 20, 152. http://doi.org/10.1186/s12916-022-02349-6
Mackenzie, I. S., MacDonald, T. M., Thompson, A. ., Morant, S. ., & Wei, L. . (2012). Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. Bmj. http://doi.org/10.1136/bmj.e4447
Thompson, A. ., Ashcroft, D. M., Owens, L. ., van Staa, T. P., & Pirmohamed, M. . (2017). Drug therapy for alcohol dependence in primary care in the UK: A Clinical Practice Research Datalink study. PLoS One. http://doi.org/10.1371/journal.pone.0173272
Thompson, A. ., Wright, A. K., Ashcroft, D. M., van Staa, T. P., & Pirmohamed, M. . (2017). Epidemiology of alcohol dependence in UK primary care: Results from a large observational study using the Clinical Practice Research Datalink. PLoS One. http://doi.org/10.1371/journal.pone.0174818
Pate, A. ., Elliott, R. A., Gkountouras, G. ., Thompson, A. ., Emsley, R. ., & Van Staa, T. . (2020). The impact of statin discontinuation and restarting rates on the optimal time to initiate statins and on the number of cardiovascular events prevented. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5023